The fundamental goals of diagnosis and resuscitation of critically ill patients are to detect, prevent, and reverse tissue hypoxia. It had been hoped that global assessment and management of oxygen delivery (DO 2 ) and consumption (VO 2 ) could achieve these goals. However, the DO 2 /VO 2 controversy continues [1]. Global assessment of DO 2 and VO 2 is controversial because of mathematical coupling of shared variables used to calculate DO 2 and VO 2 in many studies [2][3][4], because of the inability to confirm the pathologic dependence of VO 2 on DO 2 when they both are determined independently [2][3][4], and because of conflicting results of randomized controlled trials (RCTs) of supranormal oxygen delivery [5][6][7][8]. Furthermore, very recent prospective, RCTs of supranormal oxygen delivery show either no difference [7] or significantly increased mortality [8] in patients randomized to supranormal oxygen delivery.If global assessment and management of DO 2 and VO 2 are not useful, then a logical alternative is to focus on assessment and management of regional oxygenation at the organ level. Gastric tonometry is a method undergoing extensive evaluation as a tool for assessment and management of gastric oxygenation: does it work and is it ready for clinical use? The technique of gastric tonometry was reviewed in detail recently in Intensive Care Medicine [9]. The purposes of this editorial are review briefly aspects of CO 2 physiology relevant to gastric tonometry, to argue that gastric-arterial CO 2 difference is the tonometer variable of choice, and then to consider several important studies of gastric tonometry as a basis for suggesting that a new prospective RCT of gastric tonometry is required to establish its clinical efficacy.There are several cogent reasons to focus on the gut as a sentinel organ to detect occult tissue hypoxia. First, the counter current flow of the microcirculation of the gut increases the risk of gut mucosal hypoxia. Second, the gut has a higher critical DO 2 than the whole body and other vital organs [10]. Third, gut ischemia increases gut permeability, increases translocation of bacteria, and could therefore increase cytokine synthesis and release by hepatic and systemic mononuclear cells.Several lines of evidence suggest that gastric tonometer pHi may be a marker of gut hypoxia. First, if gut blood flow is decreased then gut pHi decreases [11]. Second, endotoxic shock decreases pHi [12]. Third, maintenance of gut blood flow during endotoxemia prevents the decrease of pHi [12,13]. However, does this mean that decreased gastric tonometer pHi always indicates gastric tissue hypoxia?Decreased gastric tonometer pHi may be relatively non-specific as a marker of gastric tissue hypoxia for several reasons. To develop this argument, I will review briefly the physiologic influences on pHi and other proposed measurements and calculations used in gastric tonometry (Table 1).Gastric tonometer logarithm of hydrogen ion concentration (pHi) is calculated using the measurement of CO 2 tension in ...